Systematic review of five RCTs (1,611 postmenopausal women with vulvovaginal atrophy) with pooled analyses: intravaginal DHEA v placebo improved vaginal dryness (MD -0.23) and dyspareunia (MD -0.40); adverse effects were mild and infrequent.
Meta-analysisn = 1,611
Lemos et al. Intravaginal dehydroepiandrosterone for the treatment of vulvovaginal atrophy: a systematic review and meta-analysis